MPO and Crohn disease: In line with reports on the rise of MPO activity during the active phase of the disease in patients who have ulcerative colitis and Crohn’s disease, as well as in various animal models of IBDs [40,41], we recorded the rise in MPO activity in all mice subjected to the induction of experimental colitis.